Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Tirzepatide for Sale > Tirzepatide Bulk Peptide Material with Quality Documentation Support CAS 2023788-19-2
Tirzepatide Bulk Peptide Material with Quality Documentation Support CAS 2023788-19-2 buy - large image1
Tirzepatide Bulk Peptide Material with Quality Documentation Support CAS 2023788-19-2 buy - image1
Tirzepatide Bulk Peptide Material with Quality Documentation Support CAS 2023788-19-2 buy - image2
Tirzepatide Bulk Peptide Material with Quality Documentation Support CAS 2023788-19-2 buy - image3
Tirzepatide Bulk Peptide Material with Quality Documentation Support CAS 2023788-19-2 buy - image4
Tirzepatide Bulk Peptide Material with Quality Documentation Support CAS 2023788-19-2 buy - image5
Tirzepatide Bulk Peptide Material with Quality Documentation Support CAS 2023788-19-2 buy - image6

Tirzepatide Bulk Peptide Material with Quality Documentation Support CAS 2023788-19-2

2078 Inquiries

Unit Price:

$85/G FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Reagent Grade

Content:

99%

Port:

Shanghai

Brand:

Ascent

Packaging:

1 g/bottle, 5 g/bottle, 10 g/bottle; customized gram-scale and bulk packaging available.

Price valid (until):

2026-10-02

The product will be displayed normally on the website later.
Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Semaglutide,Tirzepatide,Cagrilintide,Cosmetic Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Dual-Receptor Agonist Peptide Raw Material for Research and Development

    Product Name

    Tirzepatide

    CAS Number

    2023788-19-2

    Product Category

    Dual-Agonist Peptide Raw Material

    Appearance

    White to off-white lyophilized powder

    Purity

    ≥98% or ≥99%, subject to batch specification

    Supply Scale

    Gram-scale and larger project quantities

    Counter-Ion

    TFA, acetate or project-specific form available

    Documentation

    Batch-specific COA, HPLC and MS

    Packaging

    Sealed raw-material container, multilayer foil pouch or custom packaging


    Form note: CAS information is provided for identification. Confirm the required salt or counter-ion form before ordering.

    Shop Tirzepatide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2023788-19-2-Detailed Image 1 Shop Tirzepatide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2023788-19-2-Detailed Image 2 Shop Tirzepatide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2023788-19-2-Detailed Image 3 Shop Tirzepatide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2023788-19-2-Detailed Image 4 Shop Tirzepatide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2023788-19-2-Detailed Image 5 Shop Tirzepatide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2023788-19-2-Detailed Image 6 Shop Tirzepatide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2023788-19-2-Detailed Image 7 Shop Tirzepatide Peptide Raw Material Manufacturer for Qualified Laboratory Procurement CAS 2023788-19-2-Detailed Image 8

    Product Overview

    Tirzepatide is a 39-amino-acid modified peptide that activates both the GIP and GLP-1 receptors. It contains a C20 fatty di-acid moiety designed to support albumin binding and extended peptide exposure. Its dual-receptor profile makes it a valuable raw material for receptor pharmacology, peptide lipidation and comparative incretin research.


    ASCENT supplies Tirzepatide as a peptide raw material for analytical, laboratory and nonclinical research. It is not supplied as a finished drug product, injection, kit or consumer-use formulation.


    Mechanism and Research Value

    Tirzepatide selectively binds to and activates the receptors for GIP and GLP-1. Its dual-receptor design provides a research platform for comparing single- and dual-agonist signalling, receptor selectivity and downstream pathway interactions.

    The lipidated peptide structure is relevant to research involving albumin binding, extended-exposure peptide design, chemical modification, purification and analytical characterization.


    Core Research Applications

    • GIP and GLP-1 receptor signalling studies
    • Dual-receptor agonist and receptor-selectivity research
    • Comparison with single GLP-1 receptor agonists
    • Structure-activity relationship studies
    • Lipidated peptide and albumin-binding research
    • Peptide stability and degradation studies
    • HPLC, LC-MS and impurity-profile method development
    • Custom synthesis of related dual-agonist sequences

    ASCENT Supply Advantages

    • ASCENT provides batch-specific COA, HPLC and MS data.
    • Additional characterization such as water, peptide content, counter-ion and residual TFA may be arranged based on the project specification.
    • Custom purity, sequence, modification, packaging and scale-up requirements can be evaluated by our technical team.
    • Raw-material packaging is selected according to quantity, stability and transport requirements.

    Information to Include in Your Inquiry

    Please specify the required quantity, purity, counter-ion, analytical documents, packaging and destination country so that ASCENT can prepare an accurate quotation and technical response.

    FOR RESEARCH AND DEVELOPMENT USE ONLY. NOT FOR HUMAN OR VETERINARY USE, CLINICAL USE, PHARMACY COMPOUNDING, FORMULATION OR ADMINISTRATION.


    Frequently Asked Questions

    Can I request a sample before placing a bulk order? Yes. Sample and small-quantity requests can be evaluated according to current stock and the requested specification. 

    What quality documents are available? Batch-specific COA, HPLC and MS reports can be provided according to the agreed specification. If additional test items are required, please confirm them before placing the order.

    What package sizes can you supply? Common vial sizes include 5 mg, 10 mg, 15 mg, 20 mg, 30 mg and 60 mg. Other quantities and packaging formats can be discussed according to availability and the buyer's requirements.

    What is the minimum order quantity? The minimum order quantity depends on the selected package size and available batch. Sample quantities, individual vials and regular order quantities can be discussed with our sales team.

    Can I use my own label or customized packaging? Customized labels and packaging can be evaluated. Please provide the label artwork, package format, quantity and destination requirements for confirmation before production or packing.

    How are lead time and shipping arranged? Lead time and shipping options depend on stock status, order quantity, destination and the selected transportation method. Please provide the destination country and postal code for an accurate quotation and delivery estimate.

    How should unopened Retatrutide be stored? The unopened lyophilized material should generally be stored at -20°C or below in a dry, tightly sealed container protected from light. The storage information on the product label and batch COA should take priority.

    What information should I provide for a quotation? Please provide the required quantity, preferred vial size, destination country, required quality documents and any label or packaging requirements. Complete information helps us prepare a faster and more accurate quotation.

    Is this product intended for human use? No. This product is supplied strictly for laboratory research, analytical testing and related non-clinical applications. It is not intended for human consumption, medical diagnosis, therapeutic use, clinical applications or veterinary use.


    Research Use Disclaimer

    This product is supplied strictly for laboratory research, analytical testing and related non-clinical applications. It is not intended for human consumption, medical diagnosis, therapeutic use, clinical applications or veterinary use.

    The purchaser is responsible for ensuring that the product is handled and used in accordance with applicable laws, regulations and laboratory safety requirements.


    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Other Chemical Drugs

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Semaglutide,Tirzepatide,Cagrilintide,Cosmetic Peptides

    Location:

    ROOM 203, 2ND FLOOR, BUILDING 2, NO. 265 CHENGRUI STREET, XIASHA STREET, QIANTANG DISTRICT, HANGZHOU CITY, ZHEJIANG PROVINCE,CHINA 310020

    Payment Terms:

    TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2022

    Founded in 2022 and based in Qiantang District, Hangzhou, Zhejiang Province, China, ASCENT is a global supplier of specialty ingredients serving the pharmaceutical, biotechnology, food, nutrition, cosmetic, and personal care industries.

    Our portfolio includes active pharmaceutical ingredients (APIs), peptides, pharmaceutical intermediates, food additives, and cosmetic ingredients. We work with pharmaceutical and biotechnology companies, research institutions, food and nutrition businesses, cosmetic brands, manufacturers, formulation developers, distributors, and professional buyers worldwide.

    At ASCENT, we believe that better ingredients provide the foundation for better products. By combining reliable products, professional support, and efficient supply solutions, we help our customers simplify international sourcing, advance product development, and bring new ideas closer to market.

  • Inquiry History
    2078 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    United Kingdom

    tirzepatide

    10 MG Oct 21, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.